Ignite Creation Date:
2024-05-06 @ 8:40 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02795325
Status:
TERMINATED
Last Update Posted:
2024-07-11
First Post:
2016-05-18
Brief Title:
A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 PH1
Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization:
Novo Nordisk AS
Organization Data
Organization:
Novo Nordisk AS
Class:
INDUSTRY
Study ID:
DCR-PH1-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None